Researchers from RWJBarnabas Health and Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, as well as Tufts Medical Center and The University of Manchester, have developed and validated the first individualized risk prediction model for adults diagnosed with early-stage classic Hodgkin’s lymphoma.
Risk prediction model offers personalized outlook for early-stage Hodgkin’s lymphoma
